University of Strathclyde and Target Healthcare Limited, KTP 21_22 R4
Lead Participant:
UNIVERSITY OF STRATHCLYDE
Abstract
To embed an understanding of formulation, characterisation, and analysis techniques, to develop platform capability, and enable creation of a robust framework for the assessment of shelf-life and stability of a range of aseptically prepared Monoclonal Antibodies for patient use.
Lead Participant | Project Cost | Grant Offer |
|---|---|---|
| UNIVERSITY OF STRATHCLYDE | £196,786 | £ 98,393 |
Participant |
||
| TARGET HEALTHCARE LIMITED | ||
| INNOVATE UK | ||
| KTN LTD |
People |
ORCID iD |